Compared to Estimates, Keurig Dr Pepper (KDP) Q2 Earnings: A Look at Key Metrics
Werte in diesem Artikel
Keurig Dr Pepper, Inc (KDP) reported $4.16 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 6.1%. EPS of $0.49 for the same period compares to $0.45 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $4.14 billion, representing a surprise of +0.65%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.49.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Keurig Dr Pepper performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- U.S. Coffee: $948 million compared to the $920.79 million average estimate based on four analysts. The reported number represents a change of -0.2% year over year.Net Sales- International: $555 million versus $552.35 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.Net Sales- U.S. Refreshment Beverages: $2.66 billion versus the four-analyst average estimate of $2.66 billion. The reported number represents a year-over-year change of +10.5%.View all Key Company Metrics for Keurig Dr Pepper here>>>Shares of Keurig Dr Pepper have returned +1.6% over the past month versus the Zacks S&P 500 composite's +5.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Keurig Dr Pepper, Inc (KDP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Keurig Dr Pepper und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Keurig Dr Pepper
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Keurig Dr Pepper
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Keurig Dr Pepper Inc
Analysen zu Keurig Dr Pepper Inc
Datum | Rating | Analyst | |
---|---|---|---|
27.08.2025 | Keurig Dr Pepper Buy | UBS AG | |
17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
27.08.2025 | Keurig Dr Pepper Buy | UBS AG | |
17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
28.07.2017 | Dr Pepper Snapple Group Neutral | UBS AG | |
09.01.2017 | Dr Pepper Snapple Group Equal Weight | Barclays Capital | |
28.10.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
28.04.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
27.10.2015 | Dr Pepper Snapple Group Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
01.12.2014 | Dr Pepper Snapple Group Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Keurig Dr Pepper Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen